Clinical trial
"Serum Zinc Levels and Intake in Type 2 Diabetes: Impact on Pathogenesis and Glycemic Control"
NCT06751823 is registered in ClinicalTrials.gov with Heliopolis University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Serum Zinc Levels and Intake in Type 2 Diabetes: Impact on Pathogenesis and Glycemic Control"
- Lead sponsor
- Heliopolis University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- December 17, 2024
- Enrollment
- 195 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes